Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Opiates are a class of drugs that include both natural opioid alkaloids and semisynthetic compounds, which are derived from opium poppy or synthesized in laboratories. Common examples of opiates include morphine, meperidine (known by the brand name Demerol), hydrocodone, hydromorphone, codeine, oxycodone, and oxymorphone. These substances are primarily utilized in the medical field to manage moderate to severe acute or chronic pain, providing significant relief for patients suffering from various pain conditions. However, due to their pharmacological properties, opiates also carry a risk of abuse and dependency, making their monitoring crucial in clinical settings. The CPT® Code 83925 specifically refers to the testing of opiates and their metabolites, which is essential for assessing the presence and concentration of these substances in a patient's system. This testing is particularly important for evaluating potential toxicity levels, monitoring therapeutic use, and identifying possible cases of substance abuse. The most common specimen type collected for opiate testing is urine, as it is non-invasive and provides reliable results. However, other specimen types such as blood and meconium stool may also be utilized depending on the clinical scenario. In urine testing, various methodologies such as chromatography and immunoassay are employed to detect the presence of opiate drugs or their metabolites. For meconium specimens, quantitative liquid chromatography-tandem mass spectrometry is typically used to provide accurate measurements of opiate levels. Similarly, serum or plasma samples can be analyzed using quantitative liquid chromatography-tandem mass spectrometry or other chromatographic techniques to ensure comprehensive assessment of opiate presence in the body.
© Copyright 2026 Coding Ahead. All rights reserved.
Testing for opiates and their metabolites is indicated in several clinical scenarios, including:
The procedure for testing opiates and their metabolites involves several key steps, which are outlined below:
Post-procedure care primarily involves the communication of test results to the appropriate healthcare providers. If the test indicates the presence of opiates, further evaluation may be necessary to determine the clinical significance of the findings. This could include additional testing, adjustments to pain management strategies, or referrals to substance abuse treatment programs if misuse is suspected. Patients may also require counseling or education regarding the risks associated with opiate use, especially if they are prescribed these medications for pain management. Continuous monitoring and follow-up testing may be recommended to ensure patient safety and compliance with treatment protocols.
| Short Descr | ASSAY OF OPIATES | Medium Descr | OPIATE(S) DRUG AND METABOLITES EACH PROCEDURE | Long Descr | Opiate(s), drug and metabolites, each procedure | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
Get instant expert-level medical coding assistance.